About the role
At Kailera, we are bold, authentic and committed to our mission of developing therapies that give people the power to transform their lives and elevate their overall health. Rooted in an entrepreneurial spirit and a team-oriented culture, we are working together to advance Kailera’s mission to advance novel therapies for obesity and related conditions.
We are passionate about creating an inclusive workplace that promotes collaboration, integrity, and excellence. As we expand, we seek the most talented individuals with diverse backgrounds, cultures, perspectives, and experiences to join our team.
What You’ll Do:
The Senior Manager, Global Supply Chain reports to the Associate Director, Global Supply Chain and possesses a strong proficiency in clinical supply management and project management practices. The Senior Manager, Global Supply Chain will support the Associate Director, Global Supply Chain to ensure uninterrupted supply of Investigational Medicinal Product (IMP) for clinical studies as well as inventory of comparator drug products (if applicable).
Required location: Waltham, MA (hub-based, onsite 3-4 days per week)
Responsibilities:
- Supporting investigational drug product supply and logistics activities, including, but not limited to, demand forecasting and supply planning, IRT start-up and maintenance, label development and proof generation, packaging and labeling operations, release, distribution, expiry extension, pharmacy manual development, returns, reconciliation, destruction, and inventory management
- Support oversight in monitoring inventory levels throughout the life of a clinical trial
- Supporting oversight of packaging and labeling/distribution vendors, including relationship management
- Interpret clinical synopses and protocols to create clinical IMP demand forecasts
- Attend clinical study and cross functional meetings as needed
- Support global supply chain lead in overseeing the execution of multiple clinical trials and proactively identify potential supply chain issues, and recommend solutions to global supply chain lead
- Support clinical study close-out activities, including returned goods reconciliation and inventory destruction
- Assist with change controls and deviations as needed
- Support temperature excursion processes as required
- Support the IRT System Leads as necessary with regards to user requirement specifications and management module(s) as applicable
Required Qualifications:
- Experience managing clinical supplies for late phase, global clinical trials
- 8+ years of relevant biopharmaceutical industry experience with 5+ years in clinical supply management
- Knowledgeable in the implementation and workings of IRT systems
- Ability to create a collaborative environment and manage multiple project activities
- Strong computer skills including MS Office
- Hands-on, roll-up-your-sleeves, collaborative approach with high sense of urgency and drive for results
- Ability to think outside of the box and challenge the status quo
- Desire to work in a fast-paced, innovative environment
Education:
- Bachelor’s degree in pharmaceutical science, engineering, life sciences, or another relevant field. Advanced degree preferred
For Full Time Roles: This range represents the company’s good-faith estimate of the salary at the time of posting. Actual pay may vary based on experience, skills, qualifications, location, and internal equity. We also offer comprehensive health coverage, flexible time off, paid holidays, and a year-end shutdown. Enjoy a monthly wellness stipend, generous 401(k) match, tuition reimbursement, commuter benefits, disability and life insurance, plus annual bonus opportunities and equity grants—because your well-being and future matter to us.
EQUAL EMPLOYMENT OPPORTUNITY INFORMATION:
Kailera Therapeutics, Inc. is an Equal Opportunity Employer that does not discriminate on the basis of actual or perceived race (including traits historically associated with race, such as hair texture and protective hairstyles), color, creed, religion (including religious dress and grooming practices), national origin, ancestry, citizenship status, age (40 and over), sex or gender (including pregnancy, childbirth, pregnancy-related conditions, and lactation), gender identity or expression (including transgender status), sexual orientation, marital status, military service and veteran status, physical or mental disability, genetic information, reproductive health decisions, domestic victim status, political affiliation, or any other characteristic protected by applicable federal, state, or local laws and ordinances.
E-Verify:
Kailera Therapeutics, Inc. uses E-Verify to confirm the identity and employment eligibility of all new hires.
#LI-Hybrid
Aplyr's read
Kailera Therapeutics pioneers gene editing for rare diseases, attracting talent in quality assurance, clinical development, and scientific communications.
What's promising
- •Focus on rare diseases fills a critical healthcare niche.
- •Recent hires indicate strong emphasis on quality and regulatory compliance.
- •Advanced gene editing technologies position the company at the forefront of biotech innovation.
What to watch
- •High reliance on unproven gene editing technologies carries inherent risks.
- •Intense competition in biotech may challenge market positioning.
- •Limited public information about financial stability and long-term viability.
Why Kailera Therapeutics
- •Specializes in rare disease therapies, a less crowded market segment.
- •Emphasizes a robust quality assurance framework through strategic hires.
- •Integrates cutting-edge gene editing with a focus on clinical development.
Aplyr’s read is generated by AI from public sources. Was it useful?
About Kailera Therapeutics
Kailera Therapeutics is a biotechnology company focused on developing innovative therapies for rare diseases using advanced gene editing technologies.
